Endothelin in septic patients: Effects on cardiovascular and renal function and its relationship to proinflammatory cytokines

Citation
K. Tschaikowsky et al., Endothelin in septic patients: Effects on cardiovascular and renal function and its relationship to proinflammatory cytokines, CRIT CARE M, 28(6), 2000, pp. 1854-1860
Citations number
50
Categorie Soggetti
Aneshtesia & Intensive Care
Journal title
CRITICAL CARE MEDICINE
ISSN journal
00903493 → ACNP
Volume
28
Issue
6
Year of publication
2000
Pages
1854 - 1860
Database
ISI
SICI code
0090-3493(200006)28:6<1854:EISPEO>2.0.ZU;2-U
Abstract
Objective: To determine the time course of big-endothelin (big-ET) and its relationship to proinflammatory cytokines and organ function in sepsis. Design: Prospective analysis in patients meeting criteria of severe sepsis as part of a multicenter study (RAMSES) with an anti-tumor necrosis factor monoclonal antibody F(ab')(2) fragment (afelimomab). Setting: University hospital intensive care unit. Patients: A total of 23 nontrauma patients with severe sepsis or septic sho ck and ten multiple trauma patients. Septic patients were randomized for ad ditional experimental treatment when initial interleukin (IL)-6 serum level was above 1000 pg/mL. Interventions: Randomized patients received 1.0 mg/kg afelimomab or placebo three times daily over 3 days in addition to standard treatment. In each p atient, serial blood samples for plasma big-ET and cytokine determination a s well as clinical data were collected over 28 days. Measurements and Main Results: Significantly increased concentrations of ci rculating big-ET were found in patients with severe sepsis as compared with healthy subjects. In septic papatients, and were more elevated in randomiz ed than in nonrandomized patients. At study entry (day 0), big-ET reached a peak concentration and significantly correlated with IL-6 (r(2) =.43) and IL-8 (r(2) =.44) in patients with severe sepsis. Moreover, big-ET levels in septic patients, pooled over all observation days, correlated positively w ith pressure-adjusted heart rate, central venous pressure, pulmonary artery pressure, and pulmonary Vascular resistance and correlated inversely with creatinine clearance (r(2) = .54, .54, .59, .40, and .51, respectively, p = .0001). In all randomized septic patients, pressure-adjusted heart rate de creased from day 0 to day 2 in parallel with big-ET; however, a significant decrease in big-ET (day 0 to day 2) was only found in patients additionall y treated with afelimomab. Conclusions: In patients with severe sepsis, big-ET plasma levels are marke dly increased, even above those of multiple trauma patients, in close relat ionship to IL-6 and IL-8, and with significant correlation to renal functio n and pulmonary vascular tone.